Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acupuncture and Escitalopram for Treating Major Depression Clinical Study (AE-TMDCS): Study Design of a Randomized Controlled Trial

NCT05901571 is registered in ClinicalTrials.gov with Shanghai 7th People's Hospital as lead sponsor.

NCT NCT05901571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05901571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acupuncture and Escitalopram for Treating Major Depression Clinical Study (AE-TMDCS): Study Design of a Randomized Controlled Trial
Lead sponsor
Shanghai 7th People's Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
February 28, 2030
Enrollment
216 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major